Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)

BACKGROUND: The objective of this study was to identify prognostic factors for survival in patients with primary diffuse large B-cell lymphoma (DLBCL) of the adrenal gland. METHODS: Thirty one patients diagnosed with primary adrenal DLBCL from 14 Korean institutions and treated with R-CHOP (rituxima...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yu Ri, Kim, Jin Seok, Min, Yoo Hong, Yoon, Dok Hyun, Shin, Ho-Jin, Mun, Yeung-Chul, Park, Yong, Do, Young Rok, Jeong, Seong Hyun, Park, Joon Seong, Oh, Sung Yong, Lee, Suee, Park, Eun Kyung, Jang, Joung-Soon, Lee, Won-Sik, Lee, Hwe-Won, Eom, HyeonSeok, Ahn, Jae-sook, Jeong, Jae-Heon, Baek, Sun Kyung, Kim, Seok Jin, Kim, Won Seog, Suh, Cheolwon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445827/
https://www.ncbi.nlm.nih.gov/pubmed/22889180
http://dx.doi.org/10.1186/1756-8722-5-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445827/
https://www.ncbi.nlm.nih.gov/pubmed/22889180
http://dx.doi.org/10.1186/1756-8722-5-49

Ejemplares similares